China Biologic Products (CBPO)
Create an Alert
23.15
-0.22 -0.94%
NASDAQ
Jun 19, 3:43PM
BATS Real time
Currency in USD
China Biologic Products Revenue Quarterly YoY Growth:
-4.65% for Dec. 31, 2012China Biologic Products Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -4.65% |
| Sept. 30, 2012 | 28.62% |
| June 30, 2012 | 21.12% |
| March 31, 2012 | 37.01% |
| Dec. 31, 2011 | -0.09% |
| Sept. 30, 2011 | 14.72% |
| June 30, 2011 | 1.85% |
| March 31, 2011 | 27.21% |
| Dec. 31, 2010 | -5.16% |
| Sept. 30, 2010 | 33.15% |
| June 30, 2010 | 23.29% |
| March 31, 2010 | 28.13% |
| Dec. 31, 2009 | 185.6% |
| Sept. 30, 2009 | 95.94% |
| June 30, 2009 | 178.2% |
| March 31, 2009 | 169.4% |
| Dec. 31, 2008 | 89.41% |
| Sept. 30, 2008 | 54.39% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
CBPO Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Cornerstone Therapeutics | 71.38% |
| Insmed | |
| Exact Sciences Corporation | 0.00% |
CBPO Revenue Quarterly YoY Growth Rankings
| Overall |
66th percentile 5603 of 16782 |
| Sector |
61st percentile 543 of 1410 in Healthcare |
| Industry |
69th percentile 138 of 454 in Biotechnology |
CBPO Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -5.17% | Dec 2010 |
| Maximum | 185.6% | Dec 2009 |
| Average | 54.34% |
